nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A long-term follow-up of primary hepatic mucosa-associated lymphoid tissue lymphoma
|
Chen, Yang-Yuan |
|
|
52 |
11 |
p. 1365-1366 |
artikel |
2 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
|
Kim, Kyung Hyun |
|
|
52 |
11 |
p. 1338-1345 |
artikel |
3 |
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
|
Prentice, Ralley E. |
|
|
52 |
11 |
p. 1250-1251 |
artikel |
4 |
Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease
|
Macaluso, Fabio Salvatore |
|
|
52 |
11 |
p. 1304-1309 |
artikel |
5 |
Can red blood cell distribution width predict the severity and prognosis of hepatitis B virus–related diseases?
|
Chen, Yongxin |
|
|
52 |
11 |
p. 1372 |
artikel |
6 |
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?
|
Oliva, Salvatore |
|
|
52 |
11 |
p. 1219-1221 |
artikel |
7 |
Clinical characteristics and long-term health in celiac disease patients diagnosed in early childhood: Large cohort study
|
Koskimaa, Sara |
|
|
52 |
11 |
p. 1315-1322 |
artikel |
8 |
Comment on “Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma”
|
Binay Safer, Vildan |
|
|
52 |
11 |
p. 1374-1375 |
artikel |
9 |
Comment to “Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease”
|
Barreiro de Acosta, Manuel |
|
|
52 |
11 |
p. 1302-1303 |
artikel |
10 |
COVID-19 and intestinal inflammation: Role of fecal calprotectin
|
Ojetti, Veronica |
|
|
52 |
11 |
p. 1231-1233 |
artikel |
11 |
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
|
Macaluso, Fabio Salvatore |
|
|
52 |
11 |
p. 1222-1227 |
artikel |
12 |
Editorial Board
|
|
|
|
52 |
11 |
p. i-ii |
artikel |
13 |
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis
|
Antonelli, Giulio |
|
|
52 |
11 |
p. 1294-1301 |
artikel |
14 |
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice
|
Armuzzi, Alessandro |
|
|
52 |
11 |
p. 1259-1265 |
artikel |
15 |
Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells
|
Ruan, Tuo |
|
|
52 |
11 |
p. 1351-1358 |
artikel |
16 |
Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
|
Younes, Cherradi |
|
|
52 |
11 |
p. 1230 |
artikel |
17 |
Follicular dendritic cell sarcoma presenting as duodenal tumor
|
Liu, Fei |
|
|
52 |
11 |
p. 1367-1369 |
artikel |
18 |
Foreign body and caustic ingestions in children: A clinical practice guideline
|
Oliva, Salvatore |
|
|
52 |
11 |
p. 1266-1281 |
artikel |
19 |
Improving the screening of precancerous anal lesions in high-risk subjects with normal cytology: A longitudinal cohort study using simple tests
|
Moreau, Johanna |
|
|
52 |
11 |
p. 1359-1364 |
artikel |
20 |
In memory of Vittorio Ricci, scientist and friend
|
Romano, Marco |
|
|
52 |
11 |
p. 1377-1378 |
artikel |
21 |
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
|
|
|
|
52 |
11 |
p. 1282-1293 |
artikel |
22 |
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study
|
Lambin, Thomas |
|
|
52 |
11 |
p. 1323-1330 |
artikel |
23 |
Low frequency of COVID-19 in inflammatory bowel diseases
|
Marafini, Irene |
|
|
52 |
11 |
p. 1234-1235 |
artikel |
24 |
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
|
Nardone, Olga Maria |
|
|
52 |
11 |
p. 1236-1237 |
artikel |
25 |
Onset of ulcerative colitis during SARS-CoV-2 infection
|
Calabrese, Emma |
|
|
52 |
11 |
p. 1228-1229 |
artikel |
26 |
Painless chronic pancreatitis
|
Amodio, Antonio |
|
|
52 |
11 |
p. 1333-1337 |
artikel |
27 |
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency
|
Fiori, Giancarla |
|
|
52 |
11 |
p. 1346-1350 |
artikel |
28 |
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
|
Zingone, Fabiana |
|
|
52 |
11 |
p. 1252-1253 |
artikel |
29 |
Reply to comment: “Can red blood cell distribution width predict the severity and prognosis of hepatitis B virus–related diseases?”
|
Huang, Rui |
|
|
52 |
11 |
p. 1373 |
artikel |
30 |
Reply to comment on “Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma"
|
Benadon, Bethsabée |
|
|
52 |
11 |
p. 1376 |
artikel |
31 |
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
|
Zingone, Fabiana |
|
|
52 |
11 |
p. 1248-1249 |
artikel |
32 |
Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection
|
Mayer, Pierre |
|
|
52 |
11 |
p. 1257-1258 |
artikel |
33 |
SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?
|
Bardasi, Giulia |
|
|
52 |
11 |
p. 1244-1245 |
artikel |
34 |
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
|
Festa, Stefano |
|
|
52 |
11 |
p. 1246-1247 |
artikel |
35 |
Seronegative autoimmune atrophic gastritis is more common in elderly patients
|
Conti, Laura |
|
|
52 |
11 |
p. 1310-1314 |
artikel |
36 |
Shedding light on painless chronic pancreatitis
|
Hollenbach, Marcus |
|
|
52 |
11 |
p. 1331-1332 |
artikel |
37 |
Small bowel obstruction caused by infant compression during pregnancy
|
Hsu, Po-Ke |
|
|
52 |
11 |
p. 1370-1371 |
artikel |
38 |
Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
|
Jena, Anuraag |
|
|
52 |
11 |
p. 1254-1256 |
artikel |
39 |
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
|
Pugliese, Daniela |
|
|
52 |
11 |
p. 1238-1240 |
artikel |
40 |
Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
|
Botti, Fiorenzo |
|
|
52 |
11 |
p. 1241-1243 |
artikel |